Molecular markers for the diagnosis of human diseases including Crohn's disease
AssigneeUniversite de Sherbrooke
InventorsJean-Pierre Perreault, Daniel LaFontaine, Stephane Mercure
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversite de Sherbrooke
InventorsJean-Pierre Perreault, Daniel LaFontaine, Stephane Mercure
Estimating the term…
The present invention relates to an arbitrarily primed PCR-based method to identify genetic marker associated with a pathology, which comprises the steps of: a) collecting heterogeneous nucleic acid samples from diseased and healthy tissues; b) determining quantities of the nucleic acid pools by specific amplification of a fragment of glyceraldehyde-phosphate dehydrogenase (GAPDH) mRNA; c) amplifying nucleic acid pools of step b) using non-specific sense and antisense primers to obtain clear patterns of nucleic acid sequences; and d) subjecting amplified nucleic acid sequences to gel electrophoresis to obtain fingerprints of both diseased and healthy, wherein bands predominantly associated with diseased tissues are markers for the pathology. The present invention also relates to a RNA expression marker for the diagnosis of Crohn's disease, which comprises a 3.1 kb RNA sequence, and uses thereof.
A specific PCR primer for the diagnosis of Crohn's disease, said primer having a nucleic acid sequence as set forth in SEQ ID NO:1.
A method for the diagnosis of Crohn's disease in a patient;
Dependencies are inferred from the claim text.